1.
J Pediatr
; 144(5): 672-4, 2004 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15127012
RESUMEN
Although advances in immunosuppressive therapy have allowed prolonged patient survival, immune dysregulation observed in these patients has increased. We report an 11-year-old female heart transplant recipient in whom Glanzmann thrombasthenia was identified as part of a "multiple autoantibody syndrome" manifesting sequentially as autoimmune hemolytic anemia, thrombocytopenia, and neutropenia.